![](/img/cover-not-exists.png)
Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
C. Bolling, T. Graefe, C. Lübbing, F. Jankevicius, S. Uktveris, A. Cesas, W.-H. Meyer-Moldenhauer, H. Starkmann, M. Weigel, K. Burk, A.-R. HanauskeVolume:
24
Language:
english
Pages:
7
DOI:
10.1007/s10637-006-8221-6
Date:
November, 2006
File:
PDF, 252 KB
english, 2006